|
 |
treprostinilThis page contains recent news articles, when available, and an overview of treprostinil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The pulmonary arterial hypertension drug treprostinil (Remodulin) may be more effective than it's given ... MedPage Today Approved drug claims to ease breathlessness in patients with rare, deadly disease - Dec 24, 2009 Apparently continuous intravenous (IV) treprostinil when administered to patients of the fatal disease eased breathlessness in them. ... HealthJockey.com Breathlessness Eased in Patients With Rare, Often Fatal Disease - Dec 17, 2009 The treatment, continuous intravenous (IV) treprostinil, has already been approved by the US Food and Drug Administration for the treatment of pulmonary ... Science Daily (press release) Study Finds Life-Threatening Risks from Medication Errors in Hospitals ... - Nov 4, 2009 Epoprostenol and treprostinil inhibit the blood from clotting and also widen blood vessels to ease blood pressure in the lungs and reduce strain on the ... Reuters United Therapeutics Corporation Reports Third Quarter 2009 Financial Results - Oct 29, 2009 2009, corresponded in large part to the continued increase in the number of patients being prescribed Remodulin (treprostinil sodium) Injection and to ... Reuters Aradigm Announces Third Quarter 2009 Financial Results - Nov 5, 2009 Inc. ("Lung Rxâ€?) for the development of inhaled treprostinil in the AERx® delivery system which had previously been recorded as deferred revenue were ... WELT ONLINE New treatments for pulmonary hypertension may improve outcomes - Nov 2, 2009 Two novel medicines namely Tyvaso (Treprostinil), an inhaled medication, and Adcirca (Tadalafil), an oral therapy were noted to have been recently approved ... HealthJockey.com United Therapeutics' Viveta meets primary endpoint in PAH trial - Nov 1, 2007 The TRIUMPH-1 (TReprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension) trial was a randomized, double-blind, ... Forbes Buyback Buoys United Therapeutics - Oct 23, 2006 The company also said 130 patients have enrolled in a 200-patient trial of inhaled treprostinil. The Silver Spring, Md., company said it expects its third ... TheStreet.com - TheStreet.com (subscription) Treprostinil United Therapeutics registered, EU (pulmonary hypertensio... - Aug 22, 2005 United Therapeutics announced on 10 August 2005 the completion of the European Mutual Recognition Procedure (MRP) for treprostinil (REMODULIN) injection as ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Treprostinil Data to be Presented at Annual Meeting of the - May 6, 2008 SILVER SPRING, Md., May 6 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, ... Bloomberg Aradigm Completes Study of Inhaled Treprostinil with AERx(R) Inhaler - Nov 10, 2008 Aradigm Corporation (OTCBB:ARDM) today announced the results of a clinical trial of inhaled treprostinil in Aradigm's palm-size AERx Essence ® inhaler and ... International Business Times Treprostinil (Systemic).(Drug overview) - May 1, 2006 Treprostinil (treh-PROST-tin-il) belongs to a group of agents called prostaglandins. Prostaglandins occur naturally in the body and are involved in many ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com USA biotech: Dosing troubles snag Treprostinil bad news - Nov 19, 2008 Despite United Therapeutics Corp.'s best efforts to put a positive spin on its oral pulmonary arterial hypertension (PAH) program by highlighting a recent ... $34.00 - EIU Country Analysis - Alacra Store Treprostinil (Systemic). - Feb 1, 2006 Treprostinil (treh-PROST-tin-il) belongs to a group of agents called prostaglandins. Prostaglandins occur naturally in the body and are involved in many ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … patients treated with intravenous epoprostenol or intravenous... - Mar 2, 2007 The results do not suggest intrinsic contamination of IV treprostinil as a cause of the infections; the difference in rates might have been caused by ... $4.95 - Morbidity and Mortality Weekly Report - ECNext Intravenous Treprostinil Linked to Higher Rate of Bloodstream... - Mar 2, 2007 March 2, 2007 — Results of an investigation in 7 pulmonary arterial hypertension treatment centers showed that the overall bloodstream infection and ... Medscape New Drug Application for Inhaled Treprostinil Submitted to the US... - Jun 30, 2008 SILVER SPRING, Md., June 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation and its wholly-owned subsidiary, Lung Rx, Inc., announced today the ... RedOrbit Aradigm and United Therapeutics Sign Development and … - Oct 24, 2005 Treprostinil is currently marketed by United Therapeutics as a continuous ... A novel liposomal formulation of treprostinil delivered by the AERx System is ... Free with registration - PR Newswire - AccessMyLibrary.com Results of Inhaled Treprostinil Study Reported in the Journal of the ... - Oct 10, 2006 SATELLITE BEACH, FL -- October 10, 2006 -- Lung Rx, Inc., a wholly owned subsidiary of United Therapeutics Corporation, announced the publication of "Safety ... DG News Results of Inhaled Treprostinil Controlled Pilot Studies Reported in... - Feb 8, 2007 SATELLITE BEACH, Fla., Feb. 8 /PRNewswire-FirstCall/ -- Lung Rx, Inc., a wholly owned subsidiary of United Therapeutics Corporation , announced publication ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Results of Inhaled Treprostinil Study Reported in the ... - Oct 10, 2006 Results of Inhaled Treprostinil Study Reported in the Journal of the American College of Cardiology. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Treprostinil Data Presented at American Thoracic... - May 21, 2008 Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Results Of Inhaled Treprostinil Controlled Pilot Studies Reported In... - Feb 9, 2007 Lung Rx, Inc., a wholly owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR), announced publication in The Journal of The American College of ... Medical News Today - Medical News Today (press release) treprostinil United Therapeutics clinical data (pulmonary hypertension... - Aug 15, 2005 On 2 August 2005 United Therapeutics reported interim efficacy results from 21 patients enrolled in a phase IV study of treprostinil (REMODULIN), ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Treprostinil Treatment Appears to Improve Health of Pulmonary... - Oct 26, 2006 By Ed Susman. SALT LAKE CITY, UT -- October 26, 2006 -- Patients can handle safely be treated for up to 1 year with subcutaneous treprostinil (Remodulin) ... DG News Bank of America, Hospitality, Walt Disney: US Equity Movers - Nov 17, 2008 The Silver Spring, Maryland-based drugmaker said a drug called treprostinil failed in a study to treat pulmonary arterial hypertension. Walt Disney Co. ... Bloomberg Blood Infections Among Patients Treated with Intravenous Epoprostenol:... - Apr 5, 2007 The results do not suggest intrinsic contamination of IV treprostinil as a cause of the infections; the difference in rates might have been caused by ... Medscape Aradigm Initiates Trial of Lung Rx's Inhaled Treprostinil - Apr 8, 2008 Aradigm Corporation (OTCBB: ARDM) (the "Company") today announced it initiated a bridging clinical trial of inhaled treprostinil utilizing its AERx ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: Results of Inhaled Treprostinil Controlled Pilot... - Feb 8, 2007 Results of Inhaled Treprostinil Controlled Pilot Studies Reported in the Journal of the American College Of Cardiology. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Release: FREEDOM-C Trial of Oral Treprostinil in Pulmonary... - Nov 17, 2008 FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research FDA Approves United Therapeutics' Remodulin Label Expansion - Mar 23, 2006 FDA's Subpart H accelerated approval requirement for a phase IV post-marketing study to confirm the clinical benefit of Remodulin (treprostinil sodium). ... RedOrbit United Therapeutics's NDA for Inhaled Treprostinil Accepted for FDA … - Sep 4, 2008 US-based biotechnology company United Therapeutics and its wholly-owned subsidiary Lung Rx, have announced that the FDA has accepted for review the new drug ... RedOrbit United Therapeutics expands Triangle plans - Nov 9, 2007 It also will house the manufacturing of the oral form of treprostinil, ... Treprostinil is a synthetic compound that functions like the naturally occurring ... Bizjournals.com Event Brief of Aradigm Corp. Business Update Conference Call - Final. - Jan 16, 2008 Has ARD-1600, ARD-1500 Treprostinil for the treatment of pulmonary arterial hypertension, ... Inhaled treprostinil using AERx systems could provide a better ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Event Brief of Q4 2006 United Therapeutics Earnings Conference Call -... - Feb 20, 2007 ...study, Treprostinil Inhalation used in the management of pulmonary hypertension. 2. UTHR has 70 patients enrolled in the FREEDOM trial of oral Remodulin, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Inhaled Treprostinil NDA Submitted to FDA - Jul 2, 2008 United Therapeutics and its wholly owned subsidiary, Lung Rx, have filed an NDA for an inhaled formulation of treprostinil in the treatment of pulmonary ... FDA news - FDA news (subscription) Press Release: Aradigm and United Therapeutics Sign Development and … - Oct 24, 2005 Treprostinil is currently marketed by United Therapeutics as a continuous ... A novel liposomal formulation of treprostinil delivered by the AERx System is ... Pay-Per-View - PR Newswire - HighBeam Research … Release: New Drug Application for Inhaled Treprostinil Submitted... - Jun 30, 2008 New Drug Application for Inhaled Treprostinil Submitted to the US Food and Drug Administration. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Inhaled Treprostinil New Drug Application Filed by... - Sep 3, 2008 Inhaled Treprostinil New Drug Application Filed by FDA. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Inhaled Form of Remodulin in the Pipeline - Oct 28, 2005 Pharmaceutical manufacturer United Therapeutics, maker of treprostinil sodium (Remodulin) for pulmonary hypertension, has signed an agreement with Aradigm, ... PH Neighborhood Effetti favorevoli del Treprostinil per via inalatoria nell'ipertensio... - Nov 20, 2006 Lunedì 20 Novembre 2006 - Uno studio ha valutato gli effetti del Treprostinil ( Remodulin ) per via inalatoria sull'emodinamica polmonare e sullo scambio ... XagenaSalute Pulmonary Hypertension, January 2007 - Mar 30, 2007 ...[1] Treprostinil is a prostacyclin analogue that was approved by the US Food and ... The remaining patients were started on open-label treprostinil de novo. ... Medscape Pulmonary Hypertension, June 2006 - Jun 1, 2006 Treprostinil sodium is 1 of 5 US Food and Drug Administration-approved ... The main advantages of treprostinil over the other parenteral prostanoid, ... Medscape International Approvals: Ceplene, Reducol, Remodulin - Mar 14, 2005 The French regulatory authority, Agence Française de SĂ©curitĂ© Sanitaire des Produits de SantĂ©, has approved treprostinil sodium subcutaneous injection for ... Medscape United Therapeutics plunges 33% as oral PAH drug misses Ph III … - Nov 24, 2008 Submissions for oral treprostinil still on track; delayed filing likely ... "Finally, our inhaled treprostinil study produced highly ... $9.94 - Pharma Marketletter - Alacra Store Merger and Acquisition Scenario - Mar 22, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 12, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 28, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 22, 2006 Buyer (Total: 22). UT-15C; Beraprost SR; Remodulin (Treprostinil Sodium); Inhaled Remodulin (Treprostinil). Target (Total: 11) ... $250.00 - Revere Reports - Revere Aridigm/United Thera enter PAH accord.(Aradigm Corp., United … - Oct 31, 2005 Treprostinil is currently marketed by United Therapeutics as a continuous ... A novel liposomal formulation of treprostinil delivered by the AERx System is ... $4.95 - Pharma Marketletter - ECNext Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 29, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 22, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Postpartum pulmonary arterial hypertension.(Disease/Disorder overview) - May 1, 2007 After stabilization with dobutamine and diuresis, marked dyspnea with minimal activity continued and treatment with intravenous treprostinil was initiated. ... $4.95 - Journal of Respiratory Diseases - ECNext Long-term results after addition of sildenafil in idiopathic PAH... - Aug 1, 2006 The patient was transitioned to subcutaneous treprostinil sodium and bosentan ... She was admitted to the medical ICU where treprostinil sodium was tapered ... Free with registration - Southern Medical Journal - AccessMyLibrary.com Merger and Acquisition Scenario - Nov 15, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 2, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 27, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 8, 2008 Target (Total: 19). UT-15C (Sustained Release Oral Treprostinil); Beraprost SR; Remodulin (Treprostinil Sodium); Sustained-Release Oral Tresprostinil ... $250.00 - Revere Reports - Revere Aradigm (ARDM) and United Therapeutics (UTHR) Subsidiary Agree to … - Sep 4, 2007 ...for inhaled treprostinil using Aradigm's AERx Essence technology for the ... to the nebulizer used in an ongoing TRIUMPH (TReprostinil Sodium Inhalation ... StreetInsider.com - StreetInsider.com (subscription) Role of Prostacyclin versus Peroxisome Proliferator-Activated... - Jul 1, 2008 Treprostinil sodium was found to activate PPAR in reporter gene assays and to ... The effects of treprostinil sodium on human lung cell proliferation are ... AJRCMB (subscription) Prostacyclin Analogs and PAH - Jul 14, 2008 The second IV prostacyclin approved by the FDA is treprostinil. ... Treprostinil was initially approved by the FDA for subcutaneous (SC) delivery; ... Medscape Guideline source: American College of Chest Physicians - Dec 15, 2007 Sildenafil (Revatio) and intravenous and subcutaneous treprostinil (Remodulin) are the only therapies approved for functional class II patients with PAH. ... AAFP News Now Press Release: Corgentech Announces Scientific Presentation of... - May 18, 2006 BSIs) among PAH patients treated with IV treprostinil ... BSI in a sample of patients ... BSI in a sample of patients treated with FV treprostinil ... ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Dec 13, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 29, 2006 Target (Total: 22). Inhaled Remodulin (Treprostinil); UT-15C; Remodulin (Treprostinil Sodium); Beraprost SR. Buyer. n/a. Target ... $250.00 - Revere Reports - Revere Press Release: Improved Long-Term Outcome With Remodulin Reported … - Feb 1, 2007 FirstCall/ -- United Therapeutics Corporation ... treprostinil, in pulmonary arterial hypertension ... 2007. United Therapeutics will expand ... will join ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Jul 29, 2006 Target (Total: 22). Inhaled Remodulin (Treprostinil); UT-15C; Remodulin (Treprostinil Sodium); Beraprost SR. Buyer. Protherics Enfer TSE Diagnostic Kit ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 22, 2006 Target (Total: 22). UT-15C; Beraprost SR; Remodulin (Treprostinil Sodium); Inhaled Remodulin (Treprostinil). Buyer. n/a. Target ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 5, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 31, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 26, 2008 Beraprost SR; UT-15C; Remodulin (Treprostinil Sodium); Sustained-Release Oral ... Remodulin (Treprostinil Sodium); Viveta (Inhaled Treprostinil) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 5, 2008 Beraprost SR; Remodulin (Treprostinil Sodium); Sustained-Release Oral Tresprostinil ... Remodulin (Treprostinil Sodium); Viveta (Inhaled Treprostinil) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 20, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Study Raises Questions For United Therapeutics - Feb 27, 2007 United Therapeutics sells the prostacyclin treprostinil under the trade name Remodulin. The warning came in reaction to a recent presentation by the Centers ... Washington Post Movers: Citigroup, Lowe's, Target, Goldman Sachs - Nov 17, 2008 United Therapeutics (UTHR) says preliminary analysis of FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary ... BusinessWeek Ongoing and Completed Clinical Trials in Pulmonary Hypertension Are … - Nov 4, 2005 IV treprostinil became available and was approved for use after the last set of guidelines were released, so this agent can also be added to the list of ... DG News Aradigm Announces Second Quarter 2008 Financial Results - Aug 8, 2008 Lung Rx, Inc. used the latter device in the recently concluded Phase 3 TRIUMPH (TReprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial ... Genetic Engineering News - Genetic Engineering News (press release) Lung Rx Announces FDA Agreement to Expand TRIUMPH Study and … - Jun 12, 2006 TRIUMPH is a 12-week, multi-center, double-blind, randomized, placebo- controlled study of inhaled treprostinil in NYHA Class III and IV patients with ... Free with registration - PR Newswire - AccessMyLibrary.com Q2 2007 United Therapeutics Earnings Conference Call - Final. - Jul 31, 2007 The three unblindings are, of course, the unblinding of our pivotal trial for inhaled treprostinil, that's the TRIUMPH trial. And then the next unblinding ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Q2 2006 United Therapeutics Earnings Conference Call - Final. - Aug 1, 2006 As you know, I'm responsible for managing the inhaled treprostinil, whereas Roger manages the oral treprostinil, so I'll answer the first part of your ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Pulmonary Hypertension, March 2006 - Mar 1, 2006 Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, ... Medscape International Approvals: Tasmar, Amplimexon, IV Remodulin - Jan 17, 2006 Intravenous use of treprostinil was previously approved by the US Food and Drug Administration and the Canadian Therapeutic Products Directorate in November ... Medscape Lung Rx Announces FDA Agreement to Expand TRIUMPH Study and … - Dec 6, 2006 TRIUMPH is a 12-week, multi-center, double-blind, randomized, placebo- controlled study of inhaled treprostinil in NYHA Class III and IV patients with ... FinanzNachrichten.de Pulmonary Arterial Hypertension: The Race for the Most Effective … - Jun 4, 2005 Since then, two additional agents, treprostinil (both subcutaneous and intravenous) and inhaled iloprost, have received approval, and the additional ... RedOrbit FDA Approvals: da Vinci, MicroMed 407C, COBAS AmpliScreen HBV - Apr 29, 2005 Because the pump is currently being used to deliver treprostinil sodium ... Treprostinil sodium is indicated for the treatment of pulmonary arterial ... Medscape Merger and Acquisition Scenario - Oct 25, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 13, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Competitors by Product Report - Dec 20, 2008 Aradigm Corporation (ARDM) Products:. ARD-1550 (AERx Treprostinil) ... Beraprost SR; Gene Therapy Program; Remodulin (Treprostinil Sodium) ... $75.00 - Revere Reports - Revere Competitors by Product Report - Dec 20, 2008 Aradigm Corporation (ARDM) Products:. ARD-1550 (AERx Treprostinil) ... Beraprost SR; Gene Therapy Program; Remodulin (Treprostinil Sodium) ... $75.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 17, 2007 Target (Total: 23). UT-15C; Remodulin (Treprostinil Sodium); Beraprost SR; Gene Therapy/Progenitor Cells Program. Buyer. n/a. Target ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 17, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Its principal prostacyclin analog is Remodulin, a treprostinil-based compound ... Remodulin (treprostinil sodium) Injection, has been approved by the United ... $250.00 - Revere Reports - Revere Competitors by Product Report - Jun 21, 2008 Aradigm Corporation (ARDM) Products:. ARD-1500 (AERx Treprostinil) ... Beraprost SR; Gene Therapy Program; Remodulin (Treprostinil Sodium) ... $75.00 - Revere - Alacra Store |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |